In recent discussions, OpenAI's Sam Altman and Science VP Kevin Weil have highlighted a story involving an Australian consultant who reportedly utilized AI technologies like ChatGPT and AlphaFold to devise a treatment for his dog Rosie's cancer. The narrative gained traction after endorsements from prominent figures in the AI community, suggesting a breakthrough in AI capabilities. However, it is crucial to approach this story with caution, as there is currently no empirical evidence supporting the efficacy of the AI-designed vaccine. This situation underscores the need for a balanced evaluation of AI's potential and limitations in medical applications. At this stage, it can be observed that while the story is inspiring, a final assessment of its validity would be premature without rigorous scientific validation.